Case Report
Published on 08 Jun 2018
Long-Term Intravitreal Ranibizumab as a Potential Additional Risk Factor for Neurodegeneration in Parkinson’s Disease: A Case Report
in Neuropharmacology
- 3,563 views
- 5 citations
Case Report
Published on 08 Jun 2018
in Neuropharmacology
Original Research
Published on 21 Oct 2025
in Ophthalmology
Case Report
Published on 23 Oct 2025
in Ophthalmology
Original Research
Published on 16 Dec 2025
in Ophthalmology
Original Research
Published on 25 Jun 2025
in Ophthalmology
Mini Review
Published on 22 Aug 2022
in Inflammatory Eye Diseases
Original Research
Published on 12 Jul 2024
in Experimental Pharmacology and Drug Discovery
Mini Review
Published on 03 Apr 2017
in Neurodegeneration
Original Research
Published on 25 Apr 2023
in Visual Neuroscience
Original Research
Published on 10 Feb 2026
in Drugs Outcomes Research and Policies
Mini Review
Published on 01 Mar 2023
in Inflammatory Eye Diseases
Original Research
Published on 25 Sep 2025
in Inflammation
Original Research
Published on 11 Jun 2025
in Ophthalmology
Original Research
Published on 04 May 2022
in Retina
Systematic Review
Published on 22 Jul 2022
in Drugs Outcomes Research and Policies
Original Research
Published on 07 Aug 2025
in Retina